Sphera Funds Management Ltd. Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $73,790 - $148,365	-78,500 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$1.5 - $9.38 $240,000 - $1.5 Million	-160,000 Reduced 67.09%	78,500 $141,000
Q2 2020 Aug 13, 2020	BUY	$4.79 - $8.39 $1.14 Million - $2 Million	238,500 New	238,500 $2 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.